Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
EV/EBIT

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year EV/EBIT History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   EV/EBIT(x) 11.3063.7525.3716.0312.49

What is the latest EV/EBIT ratio of NATCO PHARMA ?

The latest EV/EBIT ratio of NATCO PHARMA is 11.30 based on Mar2023 Consolidated results.
Year EV/EBIT
Mar202311.30
Mar202263.75
Mar202125.37
Mar202016.03
Mar201912.49

How is EV/EBIT of NATCO PHARMA Trending?

Years EV/EBIT % Change
Mar2023 11.3
-82.27
Mar2022 63.75
151.28
Mar2021 25.37
58.27
Mar2020 16.03
28.34
Mar2019 12.49 -

Other Financial Ratios of NATCO PHARMA


Compare EV/EBIT ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹17,822.2 Cr 1% 0.5% 59.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹367,470.0 Cr -0.9% 0.9% 62.6% Stock Analytics
CIPLA ₹112,990.0 Cr 3.5% 4.2% 51.8% Stock Analytics
ZYDUS LIFESCIENCES ₹105,846.0 Cr 12.2% 18% 103.8% Stock Analytics
DIVIS LABORATORIES ₹103,849.0 Cr 0.8% 5.6% 19.3% Stock Analytics
DR REDDYS LABORATORIES ₹96,742.1 Cr -1% -2.4% 28.4% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

1%

0.5%

59.4%

SENSEX

1.7%

0.7%

19.2%


You may also like the below Video Courses